---
figid: PMC3784161__imm0140-0143-f1
figtitle: AKT-mammalian target of rapapmycin (mTOR) signalling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3784161
filename: imm0140-0143-f1.jpg
figlink: /pmc/articles/PMC3784161/figure/fig01/
number: F1
caption: AKT-mammalian target of rapapmycin (mTOR) signalling pathway. The mTOR forms
  two structurally and functionally distinct complexes mTORC1 and mTORC2. Activity
  of mTORC1 is critically controlled by a small GTPase, Rheb, whose activity is inhibited
  by a GTPase-activating protein, tuberous sclerosis protein 2 (TSC2) in complex with
  TSC1. Many accessory molecules as well as growth factors signal via the PI3K–AKT.
  AKT can further promote mTORC1 activity independent of TSC1/2 by phosphorylating
  PRAS40, a negative regulator of mTORC1 activity. Further mTORC1 can be activated
  via the WNT pathway, in a signalling cascade involving glycogen synthase kinase
  3 (GSK3).
papertitle: Kinase AKT controls innate immune cell development and function.
reftext: Yan Zhang, et al. Immunology. 2013 Oct;140(2):143-152.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9224739
figid_alias: PMC3784161__F1
figtype: Figure
redirect_from: /figures/PMC3784161__F1
ndex: 72b932c3-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3784161__imm0140-0143-f1.html
  '@type': Dataset
  description: AKT-mammalian target of rapapmycin (mTOR) signalling pathway. The mTOR
    forms two structurally and functionally distinct complexes mTORC1 and mTORC2.
    Activity of mTORC1 is critically controlled by a small GTPase, Rheb, whose activity
    is inhibited by a GTPase-activating protein, tuberous sclerosis protein 2 (TSC2)
    in complex with TSC1. Many accessory molecules as well as growth factors signal
    via the PI3K–AKT. AKT can further promote mTORC1 activity independent of TSC1/2
    by phosphorylating PRAS40, a negative regulator of mTORC1 activity. Further mTORC1
    can be activated via the WNT pathway, in a signalling cascade involving glycogen
    synthase kinase 3 (GSK3).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - IRS1
  - PTEN
  - SRC
  - FGR
  - FYN
  - YES1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - FOXO1
  - GSK3B
  - DDIT4L
  - DDIT4
  - RPTOR
  - AKT1S1
  - EPAS1
  - HIF1A
  - SETD2
  - ARNT
  - EIF4EBP1
  - Cancer
---
